Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof
US11535606B2 · kind B2 · utility
3Cited by
1References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2020 |
| Grant date | Dec 27, 2022 |
| Priority date | — |
| Expiry date | Jan 22, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.